January 22, 2018 / 3:40 PM / in 7 minutes BRIEF-Agenus Announces Combination Clinical Trials Of Anti-CTLA4 & Anti-PD1 Reuters Staff 
Jan 22 (Reuters) - Agenus Inc: 
* AGENUS ANNOUNCES COMBINATION CLINICAL TRIALS OF ITS ANTI-CTLA4 (AGEN1884) & ANTI-PD1 (AGEN2034) 
* AGENUS INC - ANNOUNCED LAUNCH OF COMBINATION TRIAL WITH ITS PROPRIETARY ANTI-CTLA4 AND ANTI-PD1 ANTIBODIES Source text for Eikon: Further company coverage: